about
Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature.GetReal in network meta-analysis: a review of the methodology.Get real in individual participant data (IPD) meta-analysis: a review of the methodologyMethods for meta-analysis of pharmacodynamic dose-response data with application to multi-arm studies of alogliptin.Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs.The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis.Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis.Automating network meta-analysis.Evaluation of CADD Scores in Curated Mismatch Repair Gene Variants Yields a Model for Clinical Validation and PrioritizationApplying Multiple Criteria Decision Analysis to Comparative Benefit-Risk Assessment: Choosing among Statins in Primary Prevention.A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions.A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysis.A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysisEvidence synthesis assumes additivity on the scale of measurement: response to "Rank reversal in indirect comparisons" by Norton et al
P50
Q30249003-97447EE5-8836-49DB-846F-D2B3DBB41403Q30251972-0C308166-7686-4598-BA3A-AB952A87C13FQ30988193-67A790B1-B3FC-4F32-9A6A-EB8C320E8786Q31060847-C665C834-59BD-4726-8CBD-5537B6211CECQ38237366-67E8D835-376A-4F66-96C2-5DE48C077697Q38941416-131D09A3-8223-49A4-9DCD-B3CE771E4B9CQ40438440-6566E57C-9093-482A-8061-EB000A51E841Q40859305-16041A78-D9CB-49E5-A339-5A82074ECD73Q41076527-D9AB72E4-A7BE-42C3-A0E0-565B957B58C6Q41730760-2E7FBCBD-6AA4-4614-8C33-4836D1D663D5Q43582470-9746796A-BAEA-44A9-9E0F-CB0C4D762374Q44827816-D903150C-BD8D-4EBA-9D52-FDCCE63FB410Q51065399-F75457E9-01B5-4833-9B26-D35001FAEC57Q84682474-0B543B21-1EFD-460A-ABEB-F1E90AFBE07EQ86503497-68787553-6752-413E-B585-A0486C50639B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gert van Valkenhoef
@ast
Gert van Valkenhoef
@en
Gert van Valkenhoef
@es
Gert van Valkenhoef
@nl
Gert van Valkenhoef
@sl
type
label
Gert van Valkenhoef
@ast
Gert van Valkenhoef
@en
Gert van Valkenhoef
@es
Gert van Valkenhoef
@nl
Gert van Valkenhoef
@sl
prefLabel
Gert van Valkenhoef
@ast
Gert van Valkenhoef
@en
Gert van Valkenhoef
@es
Gert van Valkenhoef
@nl
Gert van Valkenhoef
@sl
P106
P21
P2456
P31
P496
0000-0001-9231-2770